Long-Term Follow Up After Third Party Viral-Specific Cytotoxic Lymphocytes For Immunosuppression- And Epstein-Barr Virus-Associated Lymphoproliferative Disease

Sajida Kazi, Abhinav Mathur, Gwen Wilkie, Kirsty Cheal, Richard Battle, Neil McGowan, Neil Fraser, Emily Hargreaves, David Turner, John D. M. Campbell, Marc Turner, Mark A. Vickers (Corresponding Author)

Research output: Contribution to journalArticle

Abstract

Epstein-Barr virus (EBV)-associated lymphoproliferative disease is a serious complication of immunosuppression, particularly after transplantation. Treatment by reduction of immunosuppression risks graft loss after solid organ transplantation (SOT) and only 25-50% of patients respond.
Original languageEnglish
Pages (from-to)e356-e359
Number of pages4
JournalHaematologica
Volume104
Issue number8
Early online date21 Feb 2019
DOIs
Publication statusPublished - Aug 2019

Fingerprint

Human Herpesvirus 4
Immunosuppression
Lymphocytes
Organ Transplantation
Risk Reduction Behavior
Transplantation
Transplants
Therapeutics

Keywords

  • T-CELL THERAPY
  • DISORDER
  • RISK
  • MANAGEMENT
  • RECIPIENTS

ASJC Scopus subject areas

  • Hematology

Cite this

Long-Term Follow Up After Third Party Viral-Specific Cytotoxic Lymphocytes For Immunosuppression- And Epstein-Barr Virus-Associated Lymphoproliferative Disease. / Kazi, Sajida; Mathur, Abhinav; Wilkie, Gwen; Cheal, Kirsty; Battle, Richard; McGowan, Neil; Fraser, Neil; Hargreaves, Emily; Turner, David; Campbell, John D. M.; Turner, Marc; Vickers, Mark A. (Corresponding Author).

In: Haematologica, Vol. 104, No. 8, 08.2019, p. e356-e359.

Research output: Contribution to journalArticle

Kazi, S, Mathur, A, Wilkie, G, Cheal, K, Battle, R, McGowan, N, Fraser, N, Hargreaves, E, Turner, D, Campbell, JDM, Turner, M & Vickers, MA 2019, 'Long-Term Follow Up After Third Party Viral-Specific Cytotoxic Lymphocytes For Immunosuppression- And Epstein-Barr Virus-Associated Lymphoproliferative Disease', Haematologica, vol. 104, no. 8, pp. e356-e359. https://doi.org/10.3324/haematol.2018.207548
Kazi, Sajida ; Mathur, Abhinav ; Wilkie, Gwen ; Cheal, Kirsty ; Battle, Richard ; McGowan, Neil ; Fraser, Neil ; Hargreaves, Emily ; Turner, David ; Campbell, John D. M. ; Turner, Marc ; Vickers, Mark A. / Long-Term Follow Up After Third Party Viral-Specific Cytotoxic Lymphocytes For Immunosuppression- And Epstein-Barr Virus-Associated Lymphoproliferative Disease. In: Haematologica. 2019 ; Vol. 104, No. 8. pp. e356-e359.
@article{ad75936d02a647d7a8e2f0881f70240d,
title = "Long-Term Follow Up After Third Party Viral-Specific Cytotoxic Lymphocytes For Immunosuppression- And Epstein-Barr Virus-Associated Lymphoproliferative Disease",
abstract = "Epstein-Barr virus (EBV)-associated lymphoproliferative disease is a serious complication of immunosuppression, particularly after transplantation. Treatment by reduction of immunosuppression risks graft loss after solid organ transplantation (SOT) and only 25-50{\%} of patients respond.",
keywords = "T-CELL THERAPY, DISORDER, RISK, MANAGEMENT, RECIPIENTS",
author = "Sajida Kazi and Abhinav Mathur and Gwen Wilkie and Kirsty Cheal and Richard Battle and Neil McGowan and Neil Fraser and Emily Hargreaves and David Turner and Campbell, {John D. M.} and Marc Turner and Vickers, {Mark A.}",
note = "The authors would like to thank the Wellcome Trust for funding the initial set up of this bank, and the blood donors from New Zealand who provided cells.",
year = "2019",
month = "8",
doi = "10.3324/haematol.2018.207548",
language = "English",
volume = "104",
pages = "e356--e359",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "8",

}

TY - JOUR

T1 - Long-Term Follow Up After Third Party Viral-Specific Cytotoxic Lymphocytes For Immunosuppression- And Epstein-Barr Virus-Associated Lymphoproliferative Disease

AU - Kazi, Sajida

AU - Mathur, Abhinav

AU - Wilkie, Gwen

AU - Cheal, Kirsty

AU - Battle, Richard

AU - McGowan, Neil

AU - Fraser, Neil

AU - Hargreaves, Emily

AU - Turner, David

AU - Campbell, John D. M.

AU - Turner, Marc

AU - Vickers, Mark A.

N1 - The authors would like to thank the Wellcome Trust for funding the initial set up of this bank, and the blood donors from New Zealand who provided cells.

PY - 2019/8

Y1 - 2019/8

N2 - Epstein-Barr virus (EBV)-associated lymphoproliferative disease is a serious complication of immunosuppression, particularly after transplantation. Treatment by reduction of immunosuppression risks graft loss after solid organ transplantation (SOT) and only 25-50% of patients respond.

AB - Epstein-Barr virus (EBV)-associated lymphoproliferative disease is a serious complication of immunosuppression, particularly after transplantation. Treatment by reduction of immunosuppression risks graft loss after solid organ transplantation (SOT) and only 25-50% of patients respond.

KW - T-CELL THERAPY

KW - DISORDER

KW - RISK

KW - MANAGEMENT

KW - RECIPIENTS

UR - http://www.mendeley.com/research/longterm-follow-up-after-third-party-viralspecific-cytotoxic-lymphocytes-immunosuppression-epsteinba

UR - http://www.scopus.com/inward/record.url?scp=85070582249&partnerID=8YFLogxK

U2 - 10.3324/haematol.2018.207548

DO - 10.3324/haematol.2018.207548

M3 - Article

VL - 104

SP - e356-e359

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 8

ER -